Hepatology

Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study
Neeta B Amin, Amanda Darekar, Quentin M Anstee, Vincent Wai-Sun Wong, Frank Tacke, Manoli Vourvahis, Douglas S Lee, Michael Charlton, Naim Alkhouri, Atsushi Nakajima, Carla Yunis

BMJ Open Mar 2022, 12 (3) e056159; DOI: 10.1136/bmjopen-2021-056159
Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003–2018): cross-sectional study
Qianwen Li, Ling Wang, Jian Wu, Jing Wang, Yanjie Wang, Xin Zeng

BMJ Open Mar 2022, 12 (3) e058517; DOI: 10.1136/bmjopen-2021-058517
Association between intrahepatic triglyceride content in subjects with metabolically healthy abdominal obesity and risks of pre-diabetes plus diabetes: an observational study
Qiaoyan Xu, Junfeng Zhang, Haiwei Han, Ning Chen, Fangfang Lai, Yongwen Liu, Caoxin Huang, Mingzhu Lin, Wei Zhang, Shunqin Wang, Changqin Liu, Zhibin Li

BMJ Open Feb 2022, 12 (2) e057820; DOI: 10.1136/bmjopen-2021-057820
Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
Jane Chalmers, Lu Ban, Kondarapassery B Leena, Kimberley L Edwards, Jane L Grove, Guruprasad P Aithal, Kotacherry T Shenoy

BMJ Open May 2019, 9 (5) e027244; DOI: 10.1136/bmjopen-2018-027244
Prevalence and risk factors of metabolic-associated fatty liver disease during 2014–2018 from three cities of Liaoning Province: an epidemiological survey
Lin Guan, Xinhe Zhang, Haoyu Tian, Xing Jin, Hang Fan, Ningning Wang, Jing Sun, Dan Li, Jia Li, Xue Wang, Zilu Zeng, Yiling Li

BMJ Open Feb 2022, 12 (2) e047588; DOI: 10.1136/bmjopen-2020-047588
KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study
Christiaan Albert Johan Oudmaijer, Kirsten Anna Berk, Elisabeth Johanna Theresia Maria van der Louw, Rob de Man, Aart-Jan van der Lelij, Jan Hendrik Jozef Hoeijmakers, Jan IJzermans

BMJ Open Feb 2022, 12 (2) e053559; DOI: 10.1136/bmjopen-2021-053559
Transformation of identity in substance use as a pathway to recovery and the potential of treatment for hepatitis C: a systematic review protocol
Sarah R Donaldson, Andrew Radley, John F Dillon

BMJ Open Feb 2022, 12 (2) e049713; DOI: 10.1136/bmjopen-2021-049713
Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey
Xiao-Yu Hu, Yun Li, Long-Quan Li, Yuan Zheng, Jia-Hong Lv, Shu-Chun Huang, Weinong Zhang, Liang Liu, Ling Zhao, Zhuiguo Liu, Xiu-Ju Zhao

BMJ Open Apr 2018, 8 (4) e019974; DOI: 10.1136/bmjopen-2017-019974
Persistent SOMAtic symptoms ACROSS diseases — from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211)
Bernd Löwe, Viola Andresen, Omer Van den Bergh, Tobias B Huber, Olaf von dem Knesebeck, Ansgar W Lohse, Yvonne Nestoriuc, Gudrun Schneider, Stefan W Schneider, Christoph Schramm, Sonja Ständer, Eik Vettorazzi, Antonia Zapf, Meike Shedden-Mora, Anne Toussaint

BMJ Open Jan 2022, 12 (1) e057596; DOI: 10.1136/bmjopen-2021-057596
Opt-out universal HCV and HIV screening in a Canadian emergency room: a cross-sectional study
Valerie Martel-Laferriere, Jean-Guy Baril, Isabelle Alarie, Judith Leblanc, José Côté, Emmanuelle Jourdenais, Damy Horth, Gilles Lambert, Cécile Tremblay

BMJ Open Jan 2022, 12 (1) e048748; DOI: 10.1136/bmjopen-2021-048748

Main menu

Hepatology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Hepatology

Pages